Stelexis Therapeutics Competitors and Similar CompaniesClear all

Stelexis Therapeutics's competitors and similar companies include Elicio Therapeutics, Inhibitor Therapeutics, Arvinas and OnQuality Pharmaceuticals.
Stelexis Therapeutics
Stelexis Therapeutics
Stelexis Therapeutics is a cancer therapeutics company.
Elicio Therapeutics
Elicio Therapeutics
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
Inhibitor Therapeutics
Inhibitor Therapeutics
Inhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders.
Arvinas
Arvinas
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
OnQuality Pharmaceuticals
OnQuality Pharmaceuticals
OnQuality Pharmaceuticals is a pharmaceutical company specialized in the development and commercialization of drugs and drug delivery systems in the area of oncology.
Founding Date
Founding Date
2017
Founding Date
2011
Founding Date
1992
Founding Date
N/A
Founding Date
2019
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
New York, US HQ
Locations
Cambridge, US HQ
Locations
Tampa, US HQ
Locations
New Haven, US HQ
Locations
HQ
Employees
Employees
3
Employees
22
Employees
233% decrease
Employees
13329% increase
Employees
7
Valuation ($)
Valuation ($)
N/A
Valuation ($)
47.5 m
Valuation ($)
12.9 m
Valuation ($)
1.9 b
Valuation ($)
N/A

Financial

Net income
Net income
N/A
Net income
($35.2m) (FY, 2023)
Net income
($3m) (FY, 2023)
Net income
($367.3m) (FY, 2023)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 43m
Total funding raised
$ 150.3m
Total funding raised
N/A
Total funding raised
$ 111.6m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Elicio Therapeutics
HQ
Cambridge, US
Employees
22

Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.

View company
Inhibitor Therapeutics
HQ
Tampa, US
Employees
2↓ 33% decrease

Inhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders.

View company
Arvinas
HQ
New Haven, US
Employees
133↑ 29% increase

Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.

View company
OnQuality Pharmaceuticals
HQ
Employees
7

OnQuality Pharmaceuticals is a pharmaceutical company specialized in the development and commercialization of drugs and drug delivery systems in the area of oncology.

View company